Poly Medicure Limited v. Assistant Controller Of Patents And Designs

C.A.(COMM.IPD-PAT) 23/2021

Poly Medicure Limited appealed the decision of the Assistant Controller of Patents and Designs which rejected its patent application (No. 2109/DEL/2011). The rejection was based on the claim subject not fulfilling the requirements of Section 2(1)(j) of the Act. The High Court granted certain exemptions but directed further proceedings, including the presence of the Assistant Controller.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
C.A.(COMM.IPD-PAT) 23/2021
Judge(s)
Sanjeev Narula

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Poly Medicure Limited vs Assistant Controller Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCS (OS) 31/2019 & I.A. 955/2019

Akhil Bhatia & Anr.vsShri Krishan Kumar Bhatia & Ors.

The Delhi High Court issued an interim order in the dispute concerning the trademark 'ELLWIN'. Recognizing that settlement was not immediately possible, the court directed all parties to maintain the status quo regarding relevant assets and businesses. Crucially, the Registrar of Trademarks was instructed not to act on a specific assignment deed dated July 18, 2018, thereby keeping proceedings related to that transfer stayed.

patentCS(COMM) 156/2020

SAP SEvsERP TRAINING INDIA & ORS.

SAP SE successfully secured a comprehensive interim injunction against ERP Training India and associated parties in the Delhi High Court. The court found prima facie evidence of trademark and copyright infringement related to unauthorized online SAP training courses. Consequently, the defendants were ordered to immediately deactivate websites, domains, email addresses, block specific IP access points, and freeze bank accounts linked to the infringing activities.

patentCS(COMM) 439/2021

Eli Lilly And Company & Ors.vsBryan Pharmaceuticals Through Its Proprietor Mr. Laxmi Kand Pal / Navneet Kand Pal & Ors.

In this pharmaceutical dispute, Eli Lilly sued several companies for marketing its patented compound Baricitinib under a brand name ('Barinat') for rheumatoid arthritis, allegedly breaching licensing agreements that restricted use solely to COVID-19 treatment. The court addressed an application by one defendant (Defendant No. 11), who claimed the marketing was an inadvertent error and no sales had occurred. After the defendant provided undertakings not to market or sell the drug for any ailment other than COVID-19, the plaintiff agreed that no cause of action survived against this specific defendant, leading to its removal from the suit.

patentCS(COMM) 97/2022 & I.A.2301/2022, I.A.12853/2022, I.A.12858/2022

Star Sintered Products Ltd.vsKaran Bhutani

The Delhi High Court addressed an application related to trademark rectification between Star Sintered Products Ltd. and Karan Bhutani. The court noted that the defendant had withdrawn earlier applications seeking objections or rectification against the plaintiffs' trademarks. Consequently, the status of the plaintiff's marks was updated in the Registrar's records, removing references to prior objections. As a result, one specific interlocutory application (I.A. 2301/2021) was disposed of, while the court scheduled further hearings to consider the plaintiffs' claim for damages and other pending matters.

patentC.S.No.415 of 2020 (A.Nos.450 & 452 of 2022)

Dr.S.Chandralekha / M/s.Iswarya Fertility Services Pvt. Ltd.vsDr.Aravind Chander

The Madras High Court addressed applications filed by the defendant, Dr. Aravind Chander, challenging the jurisdiction and maintainability of a trademark infringement suit brought by Dr. S. Chandralekha and M/s. Iswarya Fertility Services Pvt. Ltd. The court rejected arguments regarding lack of territorial jurisdiction, finding that the plaintiff could establish personal work for gain in Chennai under Section 134(2) of the Trade Marks Act. Furthermore, the court ruled that the non-joinder of a related entity was not fatal to the suit's maintainability.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call